Aimaz Afrough
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Oncology top 5%
- CAR-T cell therapy research
- Polyomavirus and related diseases
Papers in
- Hematology 41
- Multiple Myeloma Research and Treatments 36
- Hematopoietic Stem Cell Transplantation 4
- Acute Myeloid Leukemia Research 2
- Oncology 31
- CAR-T cell therapy research 28
- Polyomavirus and related diseases 2
- Co-authors
- Richard E. Champlin (7 shared papers)Gabriela Rondón (4 shared papers)Larry Don Anderson (7 shared papers)Al-Ola A. Abdallah (7 shared papers)Zahra Mahmoudjafari (6 shared papers)Gurbakhash Kaur (7 shared papers)Amir Hamdi (5 shared papers)Leyla Osman Shune (4 shared papers)
- Journals
- Transplantation and Cellular Therapy (21 papers)Blood (9 papers)Blood Cancer Journal (7 papers)Blood Advances (7 papers)Hematological Oncology (2 papers)
- Partner nations
- United StatesIsraelAzerbaijan
In The Last Decade
Aimaz Afrough
60 papers receiving 977 citations
Aimaz Afrough's Hit Papers
Peers
Comparison fields: 5 of 38
- Hematology 591
- Oncology 442
- Toxicology 7
- Transplantation 4
- Epidemiology 34
Countries citing papers authored by Aimaz Afrough
This map shows the geographic impact of Aimaz Afrough's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aimaz Afrough with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aimaz Afrough more than expected).
Fields of papers citing papers by Aimaz Afrough
This network shows the impact of papers produced by Aimaz Afrough. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aimaz Afrough. The network helps show where Aimaz Afrough may publish in the future.
Co-authors
The 25 scholars most cited alongside Aimaz Afrough, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium Hit paper breakdown → | 2023 | 234 |
| 2 | 2023 | 93 | |
| 3 | 2023 | 68 | |
| 4 | 2014 | 43 | |
| 5 | 2015 | 42 | |
| 6 | 2024 | 40 | |
| 7 | 2023 | 38 | |
| 8 | 2025 | 31 | |
| 9 | 2023 | 29 | |
| 10 | 2023 | 27 | |
| 11 | 2024 | 25 | |
| 12 | 2018 | 23 | |
| 13 | 2023 | 20 | |
| 14 | 2014 | 18 | |
| 15 | 2016 | 18 | |
| 16 | 2025 | 18 | |
| 17 | 2019 | 17 | |
| 18 | 2017 | 15 | |
| 19 | 2022 | 14 | |
| 20 | 2023 | 13 |
About Aimaz Afrough
Aimaz Afrough is a scholar working on Hematology, Oncology, Hepatology, Molecular Biology and Genetics, having authored 69 papers that have together received 988 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (36 papers), CAR-T cell therapy research (28 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Hematopoietic Stem Cell Transplantation (4 papers), Polyomavirus and related diseases (2 papers), Hepatitis C virus research (2 papers), Acute Myeloid Leukemia Research (2 papers) and BRCA gene mutations in cancer (2 papers). The work is most often cited by research in Hematology (591 citations), Oncology (442 citations), Toxicology (7 citations), Transplantation (4 citations) and Epidemiology (34 citations). Aimaz Afrough has collaborated with scholars based in United States, Israel and Azerbaijan. Frequent co-authors include Richard E. Champlin, Gabriela Rondón, Larry Don Anderson, Al-Ola A. Abdallah, Zahra Mahmoudjafari, Gurbakhash Kaur, Amir Hamdi, Leyla Osman Shune, Hamza Hashmi and Muzaffar H. Qazilbash. Their work appears in journals such as Transplantation and Cellular Therapy, Blood, Blood Cancer Journal, Blood Advances and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.